---
title: "Promising news! "Continuing the spate of stunning news about COVID-19…"
date: 2020-11-30
source: facebook
type: Archer T. Ships shared a link.
---

# Promising news! "Continuing the spate of stunning news about COVID-19…

*November 30, 2020 · Facebook*

::::: {}
::: {}
[https://www.sciencemag.org/news/2020/11/absolutely-remarkable-no-one-who-got-modernas-vaccine-trial-developed-severe-covid-19?utm_campaign=SciMag&utm_source=JHubbard&utm_medium=Facebook](https://www.sciencemag.org/news/2020/11/absolutely-remarkable-no-one-who-got-modernas-vaccine-trial-developed-severe-covid-19?utm_campaign=SciMag&utm_source=JHubbard&utm_medium=Facebook){target="_blank"}
:::

::: {}
Promising news!\
\
\"Continuing the spate of stunning news about COVID-19 vaccines, the biotech company Moderna announced the final results of the 30,000-person efficacy trial for its candidate in a press release today: Only 11 people who received two doses of the vaccine developed COVID-19 symptoms after being infected with the pandemic coronavirus, versus 185 symptomatic cases in a placebo group. That is an efficacy of 94.1%, the company says, far above what many vaccine scientists were expecting just a few weeks ago.\
\
More impressive still, Moderna's candidate had 100% efficacy against severe disease. There were zero such COVID-19 cases among those vaccinated, but 30 in the placebo group. The company today plans to file a request for emergency use authorization (EUA) for its vaccine with the U.S. Food and Drug Administration (FDA), and is also seeking a similar green light from the European Medicines Agency.\"\
\
[https://www.sciencemag.org/news/2020/11/absolutely-remarkable-no-one-who-got-modernas-vaccine-trial-developed-severe-covid-19?utm_campaign=SciMag&utm_source=JHubbard&utm_medium=Facebook](https://www.sciencemag.org/news/2020/11/absolutely-remarkable-no-one-who-got-modernas-vaccine-trial-developed-severe-covid-19?utm_campaign=SciMag&utm_source=JHubbard&utm_medium=Facebook){target="_blank"}
:::
:::::